Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12621001390875Phase 3Recruiting
Phase 3, randomised, double-blind trial in postoperative pain comparing Celecoxib arm with Placebo arm (2 arms). Primary endpoint: Average pain on postoperative day at Day 14. Started Feb 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12621001390875.